Avance Clinical Featured in Fierce Biotech on Intranasal Expertise - Avance Clinical

With the global intranasal drug delivery market estimated to reach up to $71 billion over the next five years, Avance Clinical is seeing an increase in biotech clinical trials targeting this growing…

Introducing Fierce Biotech's 2023 Fierce 15

Avance Clinical the Australian CRO for global biotechs

Avance Clinical - The Australian & US CRO for International Biotechs

Avance Clinical on LinkedIn: Meet with Avance Clinical at Bio 2023 in Boston

AIM-HI Accelerator Fund

Avance Clinical on LinkedIn: Avance Clinical Announces North American CRO Acquisitionto Expand Later…

COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters

Avance Clinical - Delivering Global Ready Drug Development for Biotechs

Biomedicines, Free Full-Text

H1 adds $38M to series C to build out its healthcare network